Quarterly report pursuant to Section 13 or 15(d)

Equity (Details) - Schedule of stock option activity

v3.22.1
Equity (Details) - Schedule of stock option activity - Stock Options [Member]
3 Months Ended
Mar. 31, 2022
USD ($)
$ / shares
shares
Equity (Details) - Schedule of stock option activity [Line Items]  
Number of Shares, Outstanding Beginning | shares 1,362
Weighted Average Exercise Price, Outstanding Beginning | $ / shares $ 12.45
Weighted Average Remaining Contractual Term (in years),Outstanding Beginning 8 years 8 months 8 days
Aggregate Intrinsic Value, Outstanding Beginning | $
Number of Shares, Granted | shares 5
Weighted Average Exercise Price, Granted | $ / shares $ 5.89
Number of Shares, Cancelled | shares (34)
Weighted Average Exercise Price, Cancelled | $ / shares $ 8.47
Number of Shares, Outstanding Ending | shares 1,333
Weighted Average Exercise Price, Outstanding Ending | $ / shares $ 12.52
Weighted Average Remaining Contractual Term, Outstanding Ending 8 years 4 months 9 days
Aggregate Intrinsic Value, Outstanding Ending | $
Number of Shares Exercisable Ending | shares 415
Weighted Average Exercise Price, Exercisable Ending | $ / shares $ 24.23
Weighted Average Remaining Contractual Term (in years), Exercisable Ending 6 years 8 months 26 days
Aggregate Intrinsic Value, Exercisable Ending | $